ELQ-598, as a prodrug, is converted into the active drug ELQ-596 upon oral administration. ELQ-598 demonstrates potent parasitic growth inhibition capabilities ( IC 50 = 37 nM). ELQ-598 also shows low toxicity towards human cells ( IC 50 = 19 μM). ELQ-598 can be used for research into babesiosis.
Products | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Others | Products > Signaling Pathways > Parasite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.